Study 2 of 12Tirzepatide literatureSemanticScholar2010
Semantic Scholar search for Tirzepatide
Not reported in abstract.
Where it sits
this study against the rest of the tirzepatide corpus1
Preclinical · this one
9
Observational
0
Open-label
0
Randomised
2
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2010
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Key findings
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Limitations
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Elsewhere in the Tirzepatide corpus
BSerious acute biliary reporting with glucagon-like peptide-1-based therapies versus sodium-glucose cotransporter-2 inhibitors in type 2 diabetesbiorxiv-preprint · 2026 · 1.36 reporting odds ratio (95% CI 1.06-1.75; P = 0.013)HumanBReal-world treatment satisfaction and experience with once-weekly tirzepatide: Insights from prescribing physicians and people with obesity or overweight.Obesity pillars · 2026 · 90% (n=45/48) of PwO reported likelihood to recommend tirzepatide.HumanBChanges in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study.europepmc · 2026 · Weight loss of approximately 5.5 kg, n=28, P<0.001.HumanBAnnual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg in patients with type 2 diabetes in the UK.europepmc · 2026 · n=500 · Cost per patient achieving HbA1c ≤6.5%, weight loss ≥15%, and no hypoglycemia was GBP 5,650 lower with tirzepatide 5 mg compared to semaglutide 1 mg.HumanDEnhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission - a UK case study.europepmc · 2026 · ICERs: £8,327-£10,157 per QALY gained.—CTirzepatide Attenuates Diabetes-Associated Testicular Inflammation and Sperm DNA Fragmentation in Obese Diabetic Mice: Potential Pleiotropic Effects Beyond Glycemic Controlbiorxiv-preprint · 2026 · n=30 · 1.00 nmol/kg/day tirzepatide reduced HbA1c levels, p<0.001.Animal